Cargando…

The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants

Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/ MJD), is the most frequent polyglutamine (polyQ) neurodegenerative disorder. It is caused by a pathogenic expansion of the polyQ tract, located at the C-terminal region of the protein encoded by the ATXN3 gene. This gene code...

Descripción completa

Detalles Bibliográficos
Autores principales: Sousa e Silva, Rita, Sousa, André Dias, Vieira, Jorge, Vieira, Cristina P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050893/
https://www.ncbi.nlm.nih.gov/pubmed/37008788
http://dx.doi.org/10.3389/fnmol.2023.1140719
_version_ 1785014737189208064
author Sousa e Silva, Rita
Sousa, André Dias
Vieira, Jorge
Vieira, Cristina P.
author_facet Sousa e Silva, Rita
Sousa, André Dias
Vieira, Jorge
Vieira, Cristina P.
author_sort Sousa e Silva, Rita
collection PubMed
description Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/ MJD), is the most frequent polyglutamine (polyQ) neurodegenerative disorder. It is caused by a pathogenic expansion of the polyQ tract, located at the C-terminal region of the protein encoded by the ATXN3 gene. This gene codes for a deubiquitinating enzyme (DUB) that belongs to a gene family, that in humans is composed by three more genes (ATXN3L, JOSD1, and JOSD2), that define two gene lineages (the ATXN3 and the Josephins). These proteins have in common the N-terminal catalytic domain (Josephin domain, JD), that in Josephins is the only domain present. In ATXN3 knock-out mouse and nematode models, the SCA3 neurodegeneration phenotype is not, however, reproduced, suggesting that in the genome of these species there are other genes that are able to compensate for the lack of ATXN3. Moreover, in mutant Drosophila melanogaster, where the only JD protein is coded by a Josephin-like gene, expression of the expanded human ATXN3 gene reproduces multiple aspects of the SCA3 phenotype, in contrast with the results of the expression of the wild type human form. In order to explain these findings, phylogenetic, as well as, protein–protein docking inferences are here performed. Here we show multiple losses of JD containing genes across the animal kingdom, suggesting partial functional redundancy of these genes. Accordingly, we predict that the JD is essential for binding with ataxin-3 and proteins of the Josephin lineages, and that D. melanogaster mutants are a good model of SCA3 despite the absence of a gene from the ATXN3 lineage. The molecular recognition regions of the ataxin-3 binding and those predicted for the Josephins are, however, different. We also report different binding regions between the two ataxin-3 forms (wild-type (wt) and expanded (exp)). The interactors that show an increase in the interaction strength with exp ataxin-3, are enriched in extrinsic components of mitochondrial outer membrane and endoplasmatic reticulum membrane. On the other hand, the group of interactors that show a decrease in the interaction strength with exp ataxin-3 is significantly enriched in extrinsic component of cytoplasm.
format Online
Article
Text
id pubmed-10050893
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100508932023-03-30 The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants Sousa e Silva, Rita Sousa, André Dias Vieira, Jorge Vieira, Cristina P. Front Mol Neurosci Molecular Neuroscience Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/ MJD), is the most frequent polyglutamine (polyQ) neurodegenerative disorder. It is caused by a pathogenic expansion of the polyQ tract, located at the C-terminal region of the protein encoded by the ATXN3 gene. This gene codes for a deubiquitinating enzyme (DUB) that belongs to a gene family, that in humans is composed by three more genes (ATXN3L, JOSD1, and JOSD2), that define two gene lineages (the ATXN3 and the Josephins). These proteins have in common the N-terminal catalytic domain (Josephin domain, JD), that in Josephins is the only domain present. In ATXN3 knock-out mouse and nematode models, the SCA3 neurodegeneration phenotype is not, however, reproduced, suggesting that in the genome of these species there are other genes that are able to compensate for the lack of ATXN3. Moreover, in mutant Drosophila melanogaster, where the only JD protein is coded by a Josephin-like gene, expression of the expanded human ATXN3 gene reproduces multiple aspects of the SCA3 phenotype, in contrast with the results of the expression of the wild type human form. In order to explain these findings, phylogenetic, as well as, protein–protein docking inferences are here performed. Here we show multiple losses of JD containing genes across the animal kingdom, suggesting partial functional redundancy of these genes. Accordingly, we predict that the JD is essential for binding with ataxin-3 and proteins of the Josephin lineages, and that D. melanogaster mutants are a good model of SCA3 despite the absence of a gene from the ATXN3 lineage. The molecular recognition regions of the ataxin-3 binding and those predicted for the Josephins are, however, different. We also report different binding regions between the two ataxin-3 forms (wild-type (wt) and expanded (exp)). The interactors that show an increase in the interaction strength with exp ataxin-3, are enriched in extrinsic components of mitochondrial outer membrane and endoplasmatic reticulum membrane. On the other hand, the group of interactors that show a decrease in the interaction strength with exp ataxin-3 is significantly enriched in extrinsic component of cytoplasm. Frontiers Media S.A. 2023-03-15 /pmc/articles/PMC10050893/ /pubmed/37008788 http://dx.doi.org/10.3389/fnmol.2023.1140719 Text en Copyright © 2023 Sousa e Silva, Sousa, Vieira and Vieira. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Sousa e Silva, Rita
Sousa, André Dias
Vieira, Jorge
Vieira, Cristina P.
The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title_full The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title_fullStr The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title_full_unstemmed The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title_short The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
title_sort josephin domain (jd) containing proteins are predicted to bind to the same interactors: implications for spinocerebellar ataxia type 3 (sca3) studies using drosophila melanogaster mutants
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050893/
https://www.ncbi.nlm.nih.gov/pubmed/37008788
http://dx.doi.org/10.3389/fnmol.2023.1140719
work_keys_str_mv AT sousaesilvarita thejosephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT sousaandredias thejosephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT vieirajorge thejosephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT vieiracristinap thejosephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT sousaesilvarita josephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT sousaandredias josephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT vieirajorge josephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants
AT vieiracristinap josephindomainjdcontainingproteinsarepredictedtobindtothesameinteractorsimplicationsforspinocerebellarataxiatype3sca3studiesusingdrosophilamelanogastermutants